Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial.

Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 10; 62(10):2505-2517.

View in: PubMed